These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7471190)

  • 1. Adverse drug reactions in a developing country: problems encountered in a surveillance programme in a Nigerian hospital.
    Okonkwo PO; Egere JU; Ogbuokiri JE
    Cent Afr J Med; 1980 Nov; 26(11):239-42. PubMed ID: 7471190
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of hospital personnel in reporting adverse drug reactions.
    Visconti JA; Smith MC
    Am J Hosp Pharm; 1967 May; 24(5):273-5. PubMed ID: 6041781
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standards for the control of adverse effects of drugs in hospitals].
    Lopes HV
    Rev Paul Med; 1972 Jun; 79(6):222-4. PubMed ID: 4671343
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital.
    Koch-Weser J; Sidel VW; Sweet RH; Kanarek P; Eaton AE
    N Engl J Med; 1969 Jan; 280(1):20-6. PubMed ID: 5761705
    [No Abstract]   [Full Text] [Related]  

  • 5. Advantages of a unit dose drug distribution system in surveillance of adverse drug reactions.
    Bergman HD; Aoki VS; Black HJ; Dick RW; Leaverton PE; Wilson WR
    Clin Toxicol; 1972; 5(3):405-17. PubMed ID: 5073823
    [No Abstract]   [Full Text] [Related]  

  • 6. [Registration of drug adverse effects at the University of Upsala Hospital].
    Boman G; Claesson C; Göranson P
    Lakartidningen; 1980 May; 77(21):2048-50. PubMed ID: 7401757
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug utilization and adverse reactions in a general hospital.
    Sidel VW; Koch-Weser J; Barnett GO; Eaton A
    Hospitals; 1967 Jun; 41(12):80-8. PubMed ID: 6047344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surveillance of drug therapy in the hospital].
    Kewitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1487-502. PubMed ID: 611874
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretation of studies on adverse drug reactions.
    Miller RR
    Am J Hosp Pharm; 1977 Jul; 34(7):753-4. PubMed ID: 888839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological study of adverse drug reactions--a preliminary report.
    Smith JE; Canada AT
    Am J Hosp Pharm; 1967 May; 24(5):268-72. PubMed ID: 6041780
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of drug interaction information in patient medication records.
    Visconti JA
    Am J Hosp Pharm; 1969 Jul; 26(7):378-87. PubMed ID: 5797065
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction reporting: a working system.
    Michelson PA; Shields K
    Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern pharmacy practice. Better drug histories help avoid adverse reactions.
    Bowles GC
    Mod Hosp; 1969 Jun; 112(6):128. PubMed ID: 5377014
    [No Abstract]   [Full Text] [Related]  

  • 15. Public benefit and personal privacy: the problems of medical investigation in the community.
    Doll R
    Proc R Soc Med; 1974 Dec; 67(12 Pt 2):1281-5. PubMed ID: 4449877
    [No Abstract]   [Full Text] [Related]  

  • 16. [From suspected adverse reactions to verified adverse reactions - contribution of epidemiology].
    Greiser E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1540-50. PubMed ID: 417498
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiologic monitoring of adverse reactions.
    Shapiro S
    Int J Clin Pharmacol; 1973 Apr; 7(2):178-9. PubMed ID: 4731284
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for adverse drug reactions--epidemiological approaches.
    Agents Actions Suppl; 1990; 29():1-149. PubMed ID: 2316428
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-related problems and adverse drug events: negligence, litigation and prevention.
    Bhatt AD
    J Assoc Physicians India; 1999 Jul; 47(7):715-20. PubMed ID: 10778594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for adverse drug reactions.
    Bulpitt CJ
    Br J Hosp Med; 1977 Oct; 18(4):329, 333-4. PubMed ID: 912156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.